ICD-10-CM Tabular Index · Chapter 2 · FY 2026 C92

Myeloid leukemia (C92) ICD-10-CM

The C92 code range covers myeloid leukemia with 41 ICD-10-CM diagnosis codes. 30 of them are billable and valid for claim submission in fiscal year 2026, and the category headers group them but cannot themselves be billed.

✓ Built from the official CMS FY 2026 datasetEffective Oct 1, 2025 – Sep 30, 2026
41
Diagnosis Codes
30
Billable Codes
C92
Code Range
C81–C96
Parent Section

Includes

This note appears immediately under a three character code title to further define, or give examples of, the content of the category.

Code Also

A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.

Type 1 Excludes

A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

ICD-10-CM

Codes in the C92 Range 41 codes · 30 billable

41 of 41 shown
  • C92 Myeloid leukemiaNon-billable
  • C92.0 Acute myeloblastic leukemiaNon-billable
  • C92.00 Acute myeloblastic leukemia, not having achieved remission
  • C92.01 Acute myeloblastic leukemia, in remission
  • C92.02 Acute myeloblastic leukemia, in relapse
  • C92.1 Chronic myeloid leukemia, BCR/ABL-positiveNon-billable
  • C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
  • C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission
  • C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse
  • C92.2 Atypical chronic myeloid leukemia, BCR/ABL-negativeNon-billable
  • C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
  • C92.21 Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
  • C92.22 Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
  • C92.3 Myeloid sarcomaNon-billable
  • C92.30 Myeloid sarcoma, not having achieved remission
  • C92.31 Myeloid sarcoma, in remission
  • C92.32 Myeloid sarcoma, in relapse
  • C92.4 Acute promyelocytic leukemiaNon-billable
  • C92.40 Acute promyelocytic leukemia, not having achieved remission
  • C92.41 Acute promyelocytic leukemia, in remission
  • C92.42 Acute promyelocytic leukemia, in relapse
  • C92.5 Acute myelomonocytic leukemiaNon-billable
  • C92.50 Acute myelomonocytic leukemia, not having achieved remission
  • C92.51 Acute myelomonocytic leukemia, in remission
  • C92.52 Acute myelomonocytic leukemia, in relapse
  • C92.6 Acute myeloid leukemia with 11q23-abnormalityNon-billable
  • C92.60 Acute myeloid leukemia with 11q23-abnormality not having achieved remission
  • C92.61 Acute myeloid leukemia with 11q23-abnormality in remission
  • C92.62 Acute myeloid leukemia with 11q23-abnormality in relapse
  • C92.9 Myeloid leukemia, unspecifiedNon-billable
  • C92.90 Myeloid leukemia, unspecified, not having achieved remission
  • C92.91 Myeloid leukemia, unspecified in remission
  • C92.92 Myeloid leukemia, unspecified in relapse
  • C92.A Acute myeloid leukemia with multilineage dysplasiaNon-billable
  • C92.A0 Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
  • C92.A1 Acute myeloid leukemia with multilineage dysplasia, in remission
  • C92.A2 Acute myeloid leukemia with multilineage dysplasia, in relapse
  • C92.Z Other myeloid leukemiaNon-billable
  • C92.Z0 Other myeloid leukemia not having achieved remission
  • C92.Z1 Other myeloid leukemia, in remission
  • C92.Z2 Other myeloid leukemia, in relapse

About the C92 Code Range

The ICD-10 code section C92 covers various types of myeloid leukemia, a group of blood cancers that affect myeloid cells in the bone marrow. These codes differentiate forms of myeloid leukemia by type, disease phase, and remission status to guide accurate diagnosis and treatment tracking.

Within this section, codes such as C92.0 specify acute myeloblastic leukemia, including subcategories for those not in remission (C92.00), in remission (C92.01), and in relapse (C92.02). Synonyms like “acute myeloid leukemia,” “refractory acute myeloid leukemia,” and specific genetic markers help clarify code selection. Similarly, C92.1 pertains to chronic myeloid leukemia, BCR/ABL-positive, with detailed codes for remission and relapse phases. The section also encodes other forms, like atypical chronic myeloid leukemia (C92.2) and myeloid sarcoma (C92.3, also known as “chloroma” or “granulocytic sarcoma”), as well as acute promyelocytic leukemia (C92.4) and acute myelomonocytic leukemia (C92.5). These detailed codes aid medical coders in correctly documenting the leukemia subtype and clinical status, facilitating precise patient care and reporting. Understanding these distinctions helps both healthcare professionals and coders accurately use the ICD-10 code for myeloid leukemia.

Questions About This Page

How many billable codes are in the C92 range?

Of the 41 codes in this range, 30 are billable and valid for claim submission from October 1, 2025 through September 30, 2026. Category header codes group them but cannot be reported on claims.

What does the C92 range classify?

The range classifies myeloid leukemia. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.

Related References

All ICD-10-CM ChaptersAll of Chapter 2ICD-10-CM Code LookupMS-DRG ReferenceMedicare Code EditsPOA Exempt Codes

Source: CMS FY 2026 ICD-10-CM Tabular List and order file, effective October 1, 2025 through September 30, 2026.